Schadt Eric
President &Chief R&D Officer | Chief Executive Officer
1 company
Insider Signal Score
62
GoodTrades Analyzed
4
12M Win Rate
75.0%
Avg 3M Return
+20.7%
Avg 12M Return
+42.8%
Schadt Eric is a President &Chief R&D Officer at GeneDx Holdings Corp.. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $14.4M based on current market prices.
Holdings by Company
WGSMay 20, 2022
Current Shares243.4K
Value$14.36M
Net Activity+1.7K
Bought: 100.0KSold: 98.3K
Transaction History
Showing 4 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | WGS Genedx Holdings Corp. | President &Chief R&D Officer | Buy | 100,000 | $1.92 | $192,480.00 | +69.7% | -33.2% | -89.8% | |
| Apr 28, 2022 | WGS Genedx Holdings Corp. | President &Chief R&D Officer | Sell | 35,899 | $2.18 | $78,274.18 | -20.0% | -30.1% | -87.9% | |
| Jan 28, 2022 | WGS Genedx Holdings Corp. | Chief Executive Officer | Sell | 29,100 | $2.84 | $82,667.28 | -22.5% | -26.4% | -86.3% | |
| Oct 25, 2021 | WGS Genedx Holdings Corp. | Chief Executive Officer | Sale+OE | 33,332 | $7.54 | $251,323.28 | -42.3% | -59.7% | -86.9% |